Minimally-invasive deep aging clocks could improve response to COVID-19 vaccine
Minimally-invasive deep aging clocks could improve response to COVID-19 vaccine Deep Longevity, a fully-owned subsidiary of Regent Pacific (SEHK:0575.HK), specializing in the development and the application of next-generation artificial intelligence (AI) for aging and longevity research, today announced the publication of an article in Lancet Healthy Longevity titled "The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19". While the pandemic continues to unfold, targeted therapeutic solutions for COVID-19 are still not established. T...